If a device incorporates, as an integral part of its operation, an ancillary medicinal substance or companion diagnostics, the notified body must, as part of the conformity assessment process, request the opinion of a competent pharmaceutical regulatory authority on the device.
The notified body can request an opinion from Fimea in cases where an opinion should not be requested from EMA. The opi ...